UK drug-pricing ruling must be challenged, UK competition regulator tells court
The UK competition regulator told appeal judges Tuesday that it must be able to challenge a competition court ruling which invalidated the watchdog's recast decision to fine drugmakers Pfizer and Flynn...To view the full article, register now.
Already a subscriber? Click here to view full article